This is very true, and the weight of evidence in the in-vitro research that has been conducted regarding the interactions between arylcyclohexylamine dissociatives and other drugs that affect dopamine release or reuptake, as well as the ever increasing number of reports from users who have reported symptoms similar to those associated with serotonin syndrome resulting from drug combinations that primarily pose interactions related to dopamine, would seem to indicate the possibility of a counterpart to serotonin syndrome in which a flood of dopamine creates an extracellular or synaptic state which is toxic to the neurons themselves. Although the severity of the neurotoxicity posed by a "dopamine syndrome" would seem to be less than that of the more well established serotonin syndrome, the harm is compounded by dopamine's considerably more significant stimulant and excitatory effects, especially related to dangerous increases in systolic bloodpressure and other cardiovascular problems.
I would warn anyone who is considering combining methoxetamine with any other drug that affects dopamine release, reuptake, or receptor agonism, to carefully research the theoretical interactions posed by the combination, as well as any reports that are available from users who have already attempted the combination, because as the problems associated with MDAI, 5-APB, and particularily bk-MDMA used in combination with MXE have shown us, we do not fully understand the underlying mechanisms berhind methoxetamine's psychoactive action, or the risks posed by combining it with many other drugs.
Yeah, if only it were one of these two things, our troubles would be solved.